- Report
- October 2024
- 191 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- July 2021
- 120 Pages
Global
From €2370EUR$2,500USD£1,980GBP
- Report
- August 2023
- 90 Pages
Global
From €3500EUR$3,956USD£3,026GBP
- Report
- January 2025
- 132 Pages
Global
From €900EUR$950USD£752GBP
- Book
- June 2018
- 224 Pages
Clinical Mass Spectrometry (MS) is a medical device used to analyze the chemical composition of biological samples. It is used to detect and quantify small molecules, proteins, and other biomolecules in a variety of clinical applications. Clinical MS is used to diagnose and monitor diseases, detect drug abuse, and identify biomarkers for personalized medicine. It is also used to detect and quantify drugs in the body, as well as to monitor drug levels in patients.
Clinical MS is a rapidly growing market, driven by the increasing demand for personalized medicine and the need for more accurate and reliable diagnostic tests. The market is expected to continue to grow as new technologies and applications are developed.
Some of the major players in the Clinical Mass Spectrometry market include Agilent Technologies, Thermo Fisher Scientific, Waters Corporation, Shimadzu Corporation, Bruker Corporation, and PerkinElmer. Show Less Read more